Tolerance and protection against infection in the genital tract

Immunological Investigations

Volumn 39, Issue 4-5, 2010, Pages 500-525

  Russell, Michael W ^a   Mestecky, Jiri ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Genital mucosa; Immunity; Infection; Tolerance; Vaccination

Indexed keywords

BACTERIAL VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOGLOBULIN; NEISSERIA GONORRHOEAE VACCINE; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANTIBODY RESPONSE; CYTOKINE RELEASE; FEMALE GENITAL TRACT INFECTION; FETUS GROWTH; GONORRHEA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOCHEMISTRY; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INFECTION RESISTANCE; MICROBIAL COLONIZATION; MUCOSAL IMMUNITY; NEISSERIA GONORRHOEAE; NONHUMAN; PRIORITY JOURNAL; REPRODUCTION; REVIEW; SECRETIONS; SEXUALLY TRANSMITTED DISEASE; VACCINE PRODUCTION;

ANIMALS; FEMALE; GENITAL DISEASES, FEMALE; GENITAL DISEASES, MALE; HUMANS; IMMUNE TOLERANCE; IMMUNITY, MUCOSAL; MALE;

EID: 77952197413     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.3109/08820131003674834     Document Type: Review

References (130)

1. Abraham, C., Cho, J. (2009). Interleukin-23/Th17 pathways and inflammatory bowel disease. Inflamm. Bowel Dis. 15:1090-1100.
2. Anderson, D. J., Pudney, J. (2005). Human male genital tract immunity and experimental models. In: J. Mestecky, et al., eds. Mucosal Immunology, 3rd edition. Elsevier/Academic Press: Amsterdam, pp. 1647-1659.
3. Apicella, M. A., Shero, M., Jarvis, G. A., Griffiss, J. M., Mandrell, R. E., Schneider, H. (1987). Phenotypic variation in epitope expression of the Neisseria gonorrhoeae lipooligosaccharide. Infect. Immun. 55:1755-1761.
4. Atarashi, K., Nishimura, J., Shima, T., Umesaki, Y., Yamamoto, M., Onoue, M., Yagita, H., Ishii, N., Evans, R., Honda, K., Takeda, K. (2008). ATP drives lamina propria TH17 cell differentiation. Nature 455:808-812.
5. Avery, D. T., Bryant, V. L., Ma, C. S., de Waal Malefyt, R., Tangye, S. G. (2008). IL-21- induced isotype switching to IgG and IgA by human naive B cells is differentially regulated by IL-4. J. Immunol. 181:1767-1779.
6. Baba, T. W., Liska, V., Hofmann-Lehmann, R., Vlasak, J., Xu, W., Ayehunie, S., Cavacini, L. A., Posner, M. R., Katinger, H., Stiegler, G., Bernacky, B. J., Rizvi, T. A., Schmidt, R., Hill, L. R., Keeling, M. E., Lu, Y., Wright, J. E., Chou, T. C., Ruprecht, R. M. (2000). Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection. Nature Med. 6:200-206.
7. Bergquist, C., Johansson, E. L., Lagergård, T., Holmgren, J., Rudin, A. (1997). Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina. Infect. Immun. 65:2676-2684.
8. Black, C. A., Rohan, L. C., Cost, M., Watkins, S. C., Draviam, R., Alber, S., Edwards, R. P. (2000). Vaginal mucosa serves as an inductive site for tolerance. J. Immunol. 165:5077-5083.
9. Blattner, W. A. (2003). Safety and immunogenicity of a Salmonella-vectored HIV vaccine: AVEG 028. AIDS Vaccine: Abstr. 58LB, 62.
10. Boslego, J. W., Tramont, E. C., Chung, R. C., McChesney, D. G., Ciak, J., Sadoff, J. C., Piziak, M. V., Brown, J. D., Brinton, C. C., Wood, S. W., Bryan, J. R. (1991). Efficacy trial of a parenteral gonococcal pilus vaccine in men. Vaccine 9:154-162.
11. Boulton, I. C., Gray-Owen, S. D. (2002). Neisserial binding to CEACAM1 arrests the activation and proliferation of CD4+ T lymphocytes. Nature Immunol. 3:229-236.
12. Brandtzaeg, P., Carlsen, H. S., Farstad, I. N. (2005). The human mucosal B-cell system. In: J. Mestecky, et al., eds. Mucosal Immunology, 3rd edition. Elsevier/ Academic Press: Amsterdam, pp. 617-654.
13. Brandtzaeg, P., Kiyono, H., Pabst, R., Russell, M. W. (2008). Terminology: Nomenclature of mucosa-associated lymphoid tissue. Mucos. Immunol. 1:31-37.
14. Brenchley, J. M., Paiardini, M., Knox, K. S., Asher, A. I., Cervasi, B., Asher, T. E., Scheinberg, P., Price, D. A., Hage, C. A., Kholi, L. M., Khoruts, A., Frank, I., Else, J., Schacker, T., Silvestri, G., Douek, D. C. (2008). Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood 112:2826-2835.
15. Bronson, R. A., Fusi, F. M. (2005). Immunologically mediated male and female reproductive failure. In: J. Mestecky, et al., eds. Mucosal Immunology, 3rd edition. Elsevier/Academic Press: Amsterdam, pp. 1677-1691.
16. Burch, C. L., Danaher, R. J., Stein, D. C. (1997). Antigenic variation in Neisseria gonorrhoeae: Production of multiple lipooligosaccharides. J. Bacteriol. 179:982-986.
17. Cannon, J. G., Black, W. J., Nachamkin, I., Stewart, P. W. (1984). Monoclonal antibody that recognizes an outer membrane antigen common to the pathogenic Neisseria species but not to most nonpathogenic Neisseria species. Infect. Immun. 43:994-999.
18. Chegini, N., Zhao, Y., Williams, R. S., Flanders, K. C. (1994). Human uterine tissue throughout the menstrual cycle expresses transforming growth factor-b 1 (TGF b 1), TGF b 2, TGF b 3, and TGF b type II receptor messenger ribonucleic acid and protein and contains [125I]TGF b 1-binding sites. Endocrinology 135:439-449.
19. Conti, R., Shen, F., Nayyar, N., Stocum, E., Sun, J. N., Lindemann, M. J., Ho, A. W., Hai, J. H., Yu, J. J., Jung, J. W., Filler, S. G., Masso-Welch, P., Edgerton, M., Gaffen, S. L. (2009). Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J. Exp. Med. 206:299-311.
20. Cornelissen, C. N., Anderson, J. E., Boulton, I. C., Sparling, P. F. (2000). Antigenic and sequence diversity in gonococcal transferrin-binding protein A. Infect. Immun. 68:4725-4735.
21. Croy, B. A., Murphy, S. P. (2008). Maternal-fetal immunology. Immunol. Invest. 37:389-394.
22. Edwards, J. L., Apicella, M. A. (2004). The molecular mechanisms used by Neisseria gonorrhoeae to initiate infection differ between men and women. Clin. Microbiol. Rev. 17:965-981.
23. Elkins, C., Barkley, K. B., Carbonetti, N. H., Coimbre, A. J., Sparling, P. F. (1994). Immunobiology of purified recombinant outer membrane porin protein I of Neisseria gonorrhoeae. Mol. Microbiol. 14:1059-1075.
24. Eriksson, M., Meadows, S. K., Basu, S., Mselle, T. F., Wira, C. R., Sentman, C. L. (2006a). TLRs mediate IFN-g production by human uterine NK cells in endometrium. J. Immunol. 176:6219-6224.
25. Eriksson, M., Meadows, S. K., Wira, C. R., Sentman, C. L. (2004). Unique phenotype of human uterine NK cells and their regulation by endogenous TGF-b. J. Leukocyte Biol. 76:667-675.
26. Eriksson, M., Meadows, S. K., Wira, C. R., Sentman, C. L. (2006b). Endogenous transforming growth factor-b inhibits toll-like receptor mediated activation of human uterine natural killer cells. Am. J. Reprod. Immunol. 56:321-328.
27. Fahey, J. V., Prabhala, R. H., Guyre, P. M., Wira, C. R. (1999). Antigen-presenting cells in the human female reproductive tract: analysis of antigen presentation in preand post-menopausal women. Am. J. Reprod. Immunol. 42:49-57.
28. Fantini, M. C., Rizzo, A., Fina, D., Caruso, R., Becker, C., Neurath, M. F., MacDonald, T. T., Pallone, F., Monteleone, G. (2007). IL-21 regulates experimental colitis by modulating the balance between Treg and Th17 cells. Eur. J. Immunol. 37:3155-3163.
29. Feinen, B., Jerse, A. E., Gaffen, S. L., Russell, M. W. (2010). Critical role of Th17 responses in a murine model of Neisseria gonorrhoeae genital infection. Mucos. Immunol. (in press): DOI:10.1038/mi.2009.1139.
30. Fisseha, M., Chen, P., Brandt, B., Kijek, T., Moran, E., Zollinger, W. (2005). Characterization of native outer membrane vesicles from lpxL mutant strains of Neisseria meningitidis for use in parenteral vaccination. Infect. Immun. 73: 4070-4080.
31. Fox, K. K., Thomas, J. C., Weiner, D. H., Davis, R. H., Sparling, P. F., Cohen, M. S. (1999). Longitudinal evaluation of serovar-specific immunity to Neisseria gonorrhoeae. Am. J. Epidemiol. 149:353-358.
32. Galla, J. H., Spotswood, M. F., Harrison, L. A., Mestecky, J. (1985). Urinary IgA in IgA nephropathy and Henoch-Schoenlein purpura. J. Clin. Immunol. 5:298-306.
33. Gillgrass, A. E., Tang, V. A., Towarnicki, K. M., Rosenthal, K. L., Kaushic, C. (2005). Protection against genital herpes infection in mice immunized under different hormonal conditions correlates with induction of vagina-associated lymphoid tissue. J. Virol. 79: 3117-3126.
34. Giuliani, M. M., Adu-Bobie, J., Comanducci, M., Arico, B., Savino, S., Santini, L., Brunelli, B., Bambini, S., Biolchi, A., Capecchi, B., Cartocci, E., Ciucchi, L., Di Marcello, F., Ferlicca, F., Galli, B., Luzzi, E., Masignani, V., Serruto, D., Veggi, D., Contorni, M., Morandi, M., Bartalesi, A., Cinotti, V., Mannucci, D., Titta, F., Ovidi, E., Welsch, J. A., Granoff, D., Rappuoli, R., Pizza, M. (2006). A universal vaccine for serogroup B meningococcus. Proc. Natl. Acad. Sci. USA.103: 10834-10839.
35. Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., Weaver, C. T. (2005). Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nature Immunol. 6:1123-1132.
36. Hedges, S. R., Mayo, M. S., Kallman, L., Mestecky, J., Hook, E. W., Russell, M. W. (1998a). Evaluation of immunoglobulin A1 (IgA1) protease and IgA1 proteaseinhibitory activity in human female genital infection with Neisseria gonorrhoeae. Infect. Immun. 66:5826-5832.
37. Hedges, S. R., Mayo, M. S., Mestecky, J., Hook, E. W., Russell, M. W. (1999). Limited local and systemic antibody responses to Neisseria gonorrhoeae during uncomplicated genital infections. Infect. Immun. 67:3937-3946.
38. Hedges, S. R., Sibley, D. A., Mayo, M. S., Hook, E. W., III, Russell, M. W. (1998b). Cytokine and antibody responses in women infected with Neisseria gonorrhoeae: Effect of concomitant infections. J. Infect. Dis. 178:742-751.
39. Hel, Z., McGhee, J. R., Mestecky, J. (2006). HIV infection: first battle decides the war. Trends Immunol. 27:274-281.
40. Honjo, T., Kinoshita, K., Muramatsu, M. (2002). Molecular mechanism of class switch recombination: linkage with somatic hypermutation. Annu. Rev. Immunol. 20: 165-196.
41. Husby, S., Mestecky, J., Moldoveanu, Z., Holland, S., Elson, C. O. (1994). Oral tolerance in humans. T cell but not B cell tolerance after antigen feeding. J. Immunol. 152:4663-4670.
42. Hussain, L. A., Kelly, C. G., Fellowes, R., Hecht, E.-M., Wilson, J., Chapman, M., Lehner, T. (1992). Expression and gene transcript of Fc receptors for IgG, HLA class II antigens and Langerhans cells in human cervico-vaginal epithelium. Clin. Exp. Immunol. 90:530-538.
43. Imarai, M., Candia, E., Rodriguez-Tirado, C., Tognarelli, J., Pardo, M., Perez, T., Valdes, D., Reyes-Cerpa, S., Nelson, P., Acuna-Castillo, C., Maisey, K. (2008). Regulatory T cells are locally induced during intravaginal infection of mice with Neisseria gonorrhoeae. Infect. Immun. 76:5456-5465.
44. Israel, Z. R., Marx, P. A. (1995). Nonclassical mucosal antibodies predominate in genital secretions of HIV-1 infected chimpanzees. J. Med. Primatol. 24:53-60.
45. Jackson, S., Mestecky, J., Moldoveanu, Z., Spearman, P. (2005). Appendix I: Collection and processing of human mucosal secretions. In: J. Mestecky, et al., eds. Mucosal Immunology, 3rd Edn. Elsevier/Academic Press: Amsterdam, pp. 1829-1839.
46. Jackson, S., Prince, S., Kulhavy, R., Mestecky, J. (2000). False positivity of enzymelinked immunosorbent assay for measurement of secretory IgA antibodies directed at HIV type 1 antigens. AIDS Res. Hum. Retrovir. 16:595-602.
47. Jaffar, Z., Ferrini, M. E., Herritt, L. A., Roberts, K. (2009). Cutting Edge: Lung mucosal Th17-mediated responses induce polymeric Ig receptor expression by the airway epithelium and elevate secretory IgA levels. J. Immunol. 182: 4507-4511.
48. Jalanti, R., Isliker, H. (1977). Immunoglobulins in human cervico-vaginal secretions. Int. Arch. Allergy Appl. Immunol. 53:402-408.
49. Jarvis, G. A., Griffiss, J. M. (1991). Human IgA1 blockade of IgG-initiated lysis of Neisseria meningitidis is a function of antigen-binding fragment binding to the polysaccharide capsule. J. Immunol. 147:1962-1967.
50. Jerse, A. E. (1999). Experimental gonococcal genital tract infection and opacity protein expression in estradiol-treated mice. Infect. Immun. 67: 5699-5708.
51. Jerse, A. E., Cohen, M. S., Drown, P. M., Whicker, L. G., Isbey, S. F., Seifert, S., Cannon, J. G. (1994). Multiple gonococcal opacity proteins are expressed during experimental urethral infection in the male. J. Exp. Med. 179:911-920.
52. Johansson, E. L., Rudin, A., Wassén, L., Holmgren, J. (1999). Distribution of lymphocytes and adhesion molecules in human cervix and vagina. Immunology 96:272-277.
53. Johansson, M., Lycke, N. (2003). A unique population of extrathymically derived ?bTCR+CD4-CD8- T cells with regulatory functions dominates the mouse female genital tract. J. Immunol. 170: 1659-1666.
54. Kantele, A., Häkkinen, M., Moldoveanu, Z., Lu, A., Savilahti, E., Alvarez, R. D., Michalek, S., Mestecky, J. (1998). Differences in immune responses induced by oral and rectal immunizations with Salmonella typhi Ty21a: Evidence for compartmentalization within the common mucosal immune system in humans. Infect. Immun. 66:5630-5635.
55. Kasper, D. L., Rice, P. A., McCormack, W. M. (1977). Bactericidal antibody in genital infection due to Neisseria gonorrhoeae. J. Infect. Dis. 135:243-251.
56. Khader, S. A., Gaffen, S. L., Kolls, J. K. (2009). Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa. Mucos. Immunol. 2:403-411.
57. Khanolkar, A., Fuller, M. J., Zajac, A. J. (2004). CD4 T cell-dependent CD8 T cell maturation. J. Immunol. 172: 2834-2844.
58. Kim, P.-H., Kagnoff, M. F. (1990). Transforming growth factor b1 increases IgA isotype switching at the clonal level. J. Immunol. 145: 3773-3778.
59. Korn, T., Bettelli, E., Oukka, M., Kuchroo, V. K. (2009). IL-17 and Th17 cells. Annu. Rev. Immunol. 27:485-517.
60. Kozlowski, P. A., Cu-Uvin, S., Neutra, M. R., Flanigan, T. P. (1997). Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions. Infect. Immun. 65:1387-1394.
61. Kutteh, W. H., Mestecky, J., Wira, C. R. (2005). Mucosal immunity in the human female reproductive tract. In: J. Mestecky, et al., eds. Mucosal Immunology, 3rd Ed. Elsevier/Academic Press: Amsterdam, pp. 1631-1646.
62. Lambert, J. S., Keefer, M., Mulligan, M. J., Schwartz, D., Mestecky, J., Weinhold, K., Smith, C., Hsieh, R., Moldoveanu, Z., Fast, P., Forrest, B., Koff, W. (2001). A phase I safety and immunogenicity trial of UBI microparticulate monovalent HIV-1 MN oral peptide immunogen with parenteral boost in HIV-1 seronegative human subjects. Vaccine 19:3033-3042.
63. Langman, J. M., Rowland, R. (1986). The number and distribution of lymphoid follicles in the human large intestine. J. Anat. 149:189-194.
64. Lebman, D., Lee, F. D., Coffman, R. L. (1990). Mechanism for transforming growth factor-b and IL-2 enhancement of IgA expression in lipopolysaccharide- stimulated B cell cultures. J. Immunol. 144:952-959.
65. Letvin, N. L., Rao, S. S., Dang, V., Buzby, A. P., Korioth-Schmitz, B., Dombagoda, D., Parvani, J. G., Clarke, R. H., Bar, L., Carlson, K. R., Kozlowski, P. A., Hirsch, V. M., Mascola, J. R., Nabel, G. J. (2007). No evidence for consistent virus-specific immunity in simian immunodeficiency virus-exposed, uninfected rhesus monkeys. J. Virol. 81:12368-12374.
66. Lewis, L. A., Burrowes, E., Rice, P. A., Ram, S. (2010). Interactions of Neisseria with complement. In: C. A. Genco, et al., eds. Neisseria: Molecular Mechanisms of Pathogenesis. Caister Academic Press: Norfolk, UK, pp. 123-144.
67. Li, M. O., Wan, Y. Y., Sanjabi, S., Robertson, A.-K. L., Flavell, R. A. (2006). Transforming growth factor-b regulation of immune responses. Annu. Rev. Immunol. 24:99-146.
68. Macal, M., Sankaran, S., Chun, T. W., Reay, E., Flamm, J., Prindiville, T. J., Dandekar, S. (2008). Effective CD4+ T-cell restoration in gut-associated lymphoid tissue of HIVinfected patients is associated with enhanced Th17 cells and polyfunctional HIVspecific T-cell responses. Mucos. Immunol. 1:475-488.
69. Majlessi, L., Lo-Man, R., Leclerc, C. (2008). Regulatory B and T cells in infections. Microbe Infect. 10:1030-1035.
70. Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., Weaver, C. T. (2006). Transforming growth factor-b induces development of the TH17 lineage. Nature 441: 231-234.
71. Mascola, J. R., Stiegler, G., VanCott, T. C., Katinger, H., Carpenter, C. B., Hanson, C. E., Beary, H., Hayes, D., Frankel, S. S., Birx, D. L., Lewis, M. G. (2000). Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nature Med. 6: 207-210.
72. Matsuka, Y. V., Dilts, D. A., Hoiseth, S., Arumugham, R. (1998). Characterization of a subunit structure and stability of the recombinant porin from Neisseria gonorrhoeae. J. Protein Chem. 17: 719-728.
73. McChesney, D., Tramont, E. C., Boslego, J. W., Ciak, J., Sadoff, J., Brinton, C. C. (1982). Genital antibody response to a parenteral gonococcal pilus vaccine. Infect. Immun. 36: 1006-1012.
74. McGhee, J. R., Mestecky, J., Elson, C. O., Kiyono, H. (1989). Regulation of IgA synthesis and immune response by T cells and interleukins. J. Clin. Immunol. 9:175-199.
75. Mestecky, J. (1987). The common mucosal immune system and current strategies for induction of immune response in external secretions. J. Clin. Immunol. 7:265-276.
76. Mestecky, J. (2007). Humoral immune responses to the human immunodeficiency virus type-1 (HIV-1) in the genital tract as compared to other mucosal sites. J. Reprod. Immunol. 73:86-97.
77. Mestecky, J., Jackson, S., Moldoveanu, Z., Nesbit, L. R., Kulhavy, R., Prince, S. J., Sabbaj, S., Mulligan, M. J., Goepfert, P. A. (2004). Paucity of antigen-specific IgA responses in sera and external secretions of HIV-type 1-infected individuals. AIDS Res. Hum. Retroviruses 20:972-988.
78. Mestecky, J., Moro, I., Kerr, M. A., Woof, J. M. (2005). Mucosal immunoglobulins. In: J. Mestecky, et al., eds. Mucosal Immunology, 3rd Ed. Elsevier/Academic Press: Amsterdam, pp. 153-181.
79. Mestecky, J., Russell, M. W., Elson, C. O. (2007). Perspectives on mucosal vaccines: is oral tolerance a barrier? J. Immunol. 179:5633-5638.
80. Moldoveanu, Z., Huang, W.-Q., Kulhavy, R., Pate, M. S., Mestecky, J. (2005). Human male genital tract secretions: both mucosal and systemic compartments contribute to the humoral immunity. J. Immunol. 175:4127-4136.
81. Mulks, M. H., Plaut, A. G. (1978). IgA protease production as a characteristic distinguishing pathogenic from harmless Neisseriaceae. New Engl. J. Med. 299:973-976.
82. Noble, R. C., Kirk, N. M., Slagel, W. A., Vance, B. J., Somes, G. W. (1977). Recidivism among patients with gonococcal infection presenting to a venereal disease clinic. Sex. Transm. Dis. 4:39-43.
83. Ogra, P. L., Ogra, S. S. (1973). Local antibody response to poliovaccine in the female genital tract. J. Immunol. 110: 1307-1311.
84. Ouyang, W., Valdez, P. (2008). IL-22 in mucosal immunity. Mucos. Immunol. 1:335-338.
85. Pantelic, M., Kim, Y.-J., Bolland, S., Chen, I., Shively, J., Chen, T. (2005). Neisseria gonorrhoeae kills carcinoembryonic antigen-related cellular adhesion molecule 1 (CD66a)-expressing human B cells and inhibits antibody production. Infect. Immun. 73:4171-4179.
86. Park, H., Li, X. R., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., Dong, C. (2005). A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nature Immunol. 6:1133-1141.
87. Parr, E. L., Parr, M. B. (1999). Immune responses and protection against vaginal infection after nasal or vaginal immunization with attenuated herpes simplex virus type-2. Immunology 98:639-645.
88. Pistoia, V., Cocco, C. (2009). IL-21: a new player in the control of isotype switch in Peyer's patches. J. Leukocyte Biol. 85:739-743.
89. Plante, M., Cadieux, N., Rioux, C. R., Hamel, J., Brodeur, B. R., Martin, D. (1999). Antigenic and molecular conservation of the gonococcal NspA protein. Infect. Immun. 67:2855-2861.
90. Plante, M., Jerse, A., Hamel, J., Couture, F., Rioux, C. R., Brodeur, B. R., Martin, D. (2000). Intranasal immunization with gonococcal outer membrane preparations reduces the duration of vaginal colonization of mice by Neisseria gonorrhoeae. J. Infect. Dis. 182:848-855.
91. Plummer, F. A., Simonsen, J. N., Chubb, H., Slaney, L., Kimata, J., Bosire, M., Ndinya-
92. Achola, J. O., Ngugi, E. N. (1989). Epidemiologic evidence for the development of serovar-specific immunity after gonococcal infection. J. Clin. Invest. 83:1472-1476.
93. Pudney, J., Quayle, A. J., Anderson, D. J. (2005). Immunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone. Biol. Reprod. 73:1253-1263.
94. Quiding-Järbrink, M., Nordström, I., Granström, G., Kilander, A., Jertborn, M., Butcher, E. C., Lazarovits, A. I., Holmgren, J., Czerkinsky, C. (1997). Differential expression of tissue-specific adhesion molecules on human circulating antibody- forming cells after systemic, enteric, and nasal immunizations. A molecular basis for the compartmentalization of effector B cell responses. J. Clin. Invest. 99:1281-1286.
95. Raffatellu, M., George, M. l. D., Akiyama, Y., Hornsby, M. J., Nuccio, S.-P., Paixao, T. A., Butler, B. P., Chu, H., Santos, R. L., Berger, T., Mak, T. W., Tsolis, R. M., Bevins, C. L., Solnick, J. V., Dandekar, S., Bäumler, A. J. (2009). Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine. Cell Host Microb. 5:476-486.
96. Raghavan, S., Holmgren, J. (2005). CD4+CD25+ suppressor T cells regulate pathogen induced inflammation and disease. FEMS Immunol. Med. Microbiol. 44:121-127.
97. Raux, M., Finkielsztejn, L., Salmon-Ceron, D., Bouchez, H., Excler, J. L., Dulioust, E., Grouin, J. M., Sicard, D., Blondeau, C. (1999). Development and standardization of methods to evaluate the antibody response to an HIV-1 candidate vaccine in secretions and sera of seronegative vaccine recipients. J. Immunol. Meth. 222:111-124.
98. Rudin, A., Riise, G. C., Holmgren, J. (1999). Antibody responses in the lower respiratory tract and male urogenital tract in humans after nasal and oral vaccination with cholera toxin B subunit. Infect. Immun. 67:2884-2890.
99. Russell, M. W., Hook, E. W. (2009). Gonorrhea. In: L. R. Stanberry, et al., eds. Vaccines for Biodefense and Emerging and Neglected Diseases. Academic Press: Amsterdam, pp. 963-981.
100. Russell, M. W., Moldoveanu, Z., White, P. L., Sibert, G. J., Mestecky, J., Michalek, S. M. (1996). Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the cholera toxin B subunit. Infect. Immun. 64:1272-1283.
101. Russell, M. W., Reinholdt, J., Kilian, M. (1989). Anti-inflammatory activity of human IgA antibodies and their Faba fragments: inhibition of IgG-mediated complement activation. Eur. J. Immunol. 19: 2243-2249.
102. Russell, M. W., Sparling, P. F., Morrison, R. P., Cauci, S., Fidel, P. L., Martin, D., Hook, E. W., Mestecky, J. (2005). Mucosal immunology of sexually transmitted diseases. In: J. Mestecky, et al., eds. Mucosal Immunology, 3rd Ed. Academic Press: San Diego, pp. 1693-1720.
103. Sarafian, S. K., Knapp, J. S. (1989). Molecular epidemiology of gonorrhea. Clin. Microbiol. Rev. 2 Suppl.:S49-S55.
104. Schäfer, F., Kewenig, S., Stolte, N., Stahl-Hennig, C., Stallmach, A., Kaup, F. J., Zeitz, M., Schneider, T. (2002). Lack of simian immunodeficiency virus (SIV) specific IgA response in the intestine of SIV infected rhesus macaques. Gut 50:608-614.
105. Schiller, J. T., Lowy, D. R. (2006). Prospects for cervical cancer prevention by human papillomavirus vaccination. Cancer Res. 66:10229-10232.
106. Scurlock, A. M., O'Connell, C. M., Andrews, C. W., Foote, I. P., Darville, T. (2009). Genital mucosal T-helper 17 responses in Chlamydia infection and immunopathogenesis. Keystone Symposium on Th17 Cells in Health and Disease: Abstract #309.
107. Seifert, H. S., Wright, C. J., Jerse, A. E., Cohen, M. S., Cannon, J. G. (1994). Multiple gonococcal pilin antigenic variants are produced during experimental human infections. J. Clin. Invest. 93: 2744-2749.
108. Shedlock, D. J., Shen, H. (2003). Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 300:337-339.
109. Song, W., Condron, S., Mocca, B. T., Veit, S. J., Hill, D., Abbas, A., Jerse, A. E. (2008). Local and humoral immune responses against primary and repeat Neisseria gonorrhoeae genital tract infections of 17b-estradiol-treated mice. Vaccine 26: 5741-5751.
110. Suvas, S., Rouse, B. T. (2006). Treg control of antimicrobial T cell responses. Curr. Opin. Immunol. 18:344-348.
111. Van Ginkel, F. W., Jackson, R. J., Yuki, Y., McGhee, J. R. (2000). Cutting edge: The mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues. J. Immunol. 165:4778-4782.
112. Veazey, R. S., Marx, P. A., Lackner, A. A. (2003a). Vaginal CD4+ T cells express high levels of CCR5 and are rapidly depleted in simian immunodeficiency virus infection. J. Infect. Dis. 187:769-776.
113. Veazey, R. S., Shattock, R. J., Pope, M., Kirijan, J. C., Jones, J., Hu, Q., Ketas, T., Marx, P. A., Klasse, P. J., Burton, D. R., Moore, J. P. (2003b). Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120. Nature Med. 9:343-346.
114. Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., Stockinger, B. (2006). TGFb in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24:179-189.
115. Waldo, F. B., van den Wall Bake, A. W. L., Mestecky, J., Husby, S. (1994). Suppression of the immune response by nasal immunization. Clin. Immunol. Immunopath. 72:30-34.
116. Wallace, P. K., Yeaman, G. R., Johnson, K., Collins, J. E., Guyre, P. M., Wira, C. R. (2001). MHC class II expression and antigen presentation by human endometrial cells. J. Steroid Biochem. Mol. Biol. 76:203-211.
117. Wang, J. C., Livingstone, A. M. (2003). Cutting edge: CD4+ T cell help can be essential for primary CD8+ T cell responses in vivo. J. Immunol. 171:6339-6343.
118. Wetzler, L. M., Blake, M. S., Barry, K., Gotschlich, E. C. (1992). Gonococcal porin vaccine evaluation: Comparison of Por proteosomes, liposomes, and blebs isolated from rmp deletion mutants. J. Infect. Dis. 166:551-555.
119. White, H. D., Crassi, K. M., Givan, A. L., Stern, J. E., Gonzalez, J. L., Memoli, V. A., Green, W. R., Wira, C. R. (1997a). CD3+CD8+ CTL activity within the human female reproductive tract. Influence of stage of the menstrual cycle and menopause. J. Immunol. 158:3017-3027.
120. White, H. D., Crassi, K. M., Wira, C. R. (1997b). Cytolytic functional activities of NK cells and cytotoxic T lymphocytes (CTL) are coordinately regulated in the human female reproductive tract. In: A. J. Husband, et al., eds. Mucosal Solutions: Advances in Mucosal Immunology, Vol.1. University of Sydney: Sydney, Australia, pp. 385-391.
121. WHO (2001). Global prevalence and incidence of selected curable sexually transmitted infections: Overview and estimates (Geneva: World Health Organization).
122. Wira, C. R., Crane-Godreau, M. A., Grant, K. S. (2005). Endocrine regulation of the mucosal immune system in the female reproductive tract. In: J. Mestecky, et al., eds. Mucosal Immunology, 3rd edn. Elsevier/Academic Press: Amsterdam, pp. 1661-1676.
123. Wira, C. R., Roche, M. A., Rossoll, R. M. (2002). Antigen presentation by vaginal cells: role of TGFb as a mediator of estradiol inhibition of antigen presentation. Endocrinology 143:2872-2879.
124. Wira, C. R., Rossoll, R. M. (1995a). Antigen-presenting cells in the female reproductive tract: influence of sex hormones on antigen presentation in the vagina. Immunology 84:505-508.
125. Wira, C. R., Rossoll, R. M. (1995b). Antigen-presenting cells in the female reproductive tract: influence of the estrous cycle on antigen presentation by uterine epithelial and stromal cells. Endocrinology 136:4526-4534.
126. Wira, C. R., Rossoll, R. M. (2003). Oestradiol regulation of antigen presentation by uterine stromal cells: role of transforming growth factor-b production by epithelial cells in mediating antigen-presenting cell function. Immunology 109:398-406.
127. Wright, P. F., Mestecky, J., McElrath, M. J., Keefer, M. C., Gorse, G. J., Goepfert, P. A., Moldoveanu, Z., Schwartz, D., Spearman, P. W., El Habib, R., Spring, M. D., Zhu, Y. W., Smith, C., Flores, J., Weinhold, K. J. (2004). Comparison of systemic and mucosal delivery of 2 canarypox virus vaccines expressing either HIV-1 genes or the gene for rabies virus G protein. J. Infect. Dis. 189:1221-1231.
128. Wu, H. Y., Abdu, S., Stinson, D., Russell, M. W. (2000). Generation of female genital tract antibody responses by local or central (common) mucosal immunization. Infect. Immun. 68:5539-5545.
129. Xu, W., Santini, P. A., Sullivan, J. S., He, B., Shan, M., Ball, S. C., Dyer, W. B., Ketas, T. J., Chadburn, A., Cohen-Gould, L., Knowles, D. M., Chiu, A., Sanders, R. W., Chen, K., Cerutti, A. (2009). HIV-1 evades virus-specific IgG2 and IgA responses by targeting systemic and intestinal B cells via long-range intercellular conduits. Nature Immunol. 10:1008-1017.
130. Yeaman, G. R., Guyre, P. M., Fanger, M. W., Collins, J. E., White, H. D., Rathbun, W., Orndorff, K. A., Gonzalez, J., Stern, J. E., Wira, C. R. (1997). Unique CD8+ T cellrich lymphoid aggregates in human uterine endometrium. J. Leukocyte Biol. 61:427-435.